Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients

NCT05100173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1192

Last updated 2021-11-22

No results posted yet for this study

Summary

The purpose of this trail is to evaluate the performance of Genetron IDH1 PCR Kit in Glioma patients using real-time PCR method.

Conditions

  • Glioma, Malignant
  • Glioma, Mixed

Sponsors & Collaborators

  • Huashan Hospital

    collaborator OTHER
  • Zhejiang University

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • The First Hospital of Jilin University

    collaborator OTHER
  • Genetron Health

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-13
Primary Completion
2016-09-22
Completion
2016-12-08

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05100173 on ClinicalTrials.gov